Continuous Price Reduction Expected to Shrink Pharmaceutical Industry

The Korea Pharmaceutical Manufacturers Association (KPMA) has announced that the continuing medicine price reductions initiated by the government is not only hindering the growth of the pharmaceutical industry which would rise to a core industry in the bioengineering era, but also played an insignificant role in improving the financial condition of Health Insurance.

KPMA chairman Kim Jeong-...